发明名称 |
Compositions and methods for inhibiting expression of the ALAS1 gene |
摘要 |
The invention relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the ALAS1 gene, and methods of using such dsRNA compositions to alter (e.g., inhibit) expression of ALAS1. |
申请公布号 |
US9133461(B2) |
申请公布日期 |
2015.09.15 |
申请号 |
US201313835613 |
申请日期 |
2013.03.15 |
申请人 |
Alnylam Pharmaceuticals, Inc.;Icahn School of Medicine at Mount Sinai |
发明人 |
Bettencourt Brian;Fitzgerald Kevin;Querbes William;Desnick Robert J.;Yasuda Makiko |
分类号 |
C12N15/113;A61K31/713 |
主分类号 |
C12N15/113 |
代理机构 |
Lando & Anastasi, LLP |
代理人 |
Lando & Anastasi, LLP |
主权项 |
1. A double-stranded ribonucleic acid (dsRNA) for inhibiting expression of ALAS1, wherein said dsRNA comprises a sense strand and an antisense strand, wherein:
(i) the antisense strand is complementary to at least nucleotides 871-889 of SEQ ID NO:1 and comprises SEQ ID NO:1296, (ii) the sense strand comprises at least 15 contiguous nucleotides from SEQ ID NO:1295, (iii) a ligand and linker with a structure as shown below is attached to the 3′ end of the sense strand of the dsRNAand
(iv) the dsRNA comprises one or more nucleotides with a modification chosen from a 2′-O-methyl modified nucleotide, a 2′-fluoro modified nucleotide, or both. |
地址 |
Cambridge MA US |